Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with 90 Y Glass Microspheres.

MLA

Watanabe, Masao, et al. “Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with 90 Y Glass Microspheres.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 64, no. 7, July 2023, pp. 1102–08. EBSCOhost, https://doi.org/10.2967/jnumed.122.264996.

APA

Watanabe, M., Grafe, H., Theysohn, J., Schaarschmidt, B., Ludwig, J., Jochheim, L., Jeschke, M., Schmidt, H., Fendler, W. P., Moraitis, A., Herrmann, K., Pomykala, K. L., & Weber, M. (2023). Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with 90 Y Glass Microspheres. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 64(7), 1102–1108. https://doi.org/10.2967/jnumed.122.264996

Chicago

Watanabe, Masao, Hong Grafe, Jens Theysohn, Benedikt Schaarschmidt, Johannes Ludwig, Leonie Jochheim, Matthias Jeschke, et al. 2023. “Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with 90 Y Glass Microspheres.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 64 (7): 1102–8. doi:10.2967/jnumed.122.264996.